The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,760.00
Bid: 1,759.00
Ask: 1,760.00
Change: 4.00 (0.23%)
Spread: 1.00 (0.057%)
Open: 1,743.50
High: 1,760.50
Low: 1,740.50
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: UK stocks advance as investors shrug off weak data

Thu, 21st Aug 2014 12:01

- Mining stocks fall as Chinese data weakens- Eurozone PMIs and UK retail sales disappoint- US data, Jackson Hole aheadtechMARK 2,810.76 +0.50%FTSE 100 6,772.04 +0.25%FTSE 250 15,797.15 +0.31%Falls in the heavyweight mining sector weren't enough to stop the FTSE 100 from advancing on Thursday despite a barrage of weak economic data from across the globe."The data seen so far today hasn't been great but that hasn't affected investors' appetite for risk, as European indices have continued their march higher," said market analyst Craig Erlam from Alpari UK.London's Footsie was trading 0.25% higher at 6,772 by midday.Economic data misses forecastsMining stocks were under pressure in morning trade after manufacturing data from top metals consumer China disappointed, while metals prices weakened on the back of a stronger US dollar.The HSBC China manufacturing purchasing managers' index (PMI) dropped from 51.7 to a three-month low 50.3 in August. The fall ended a streak of four straight monthly improvements in activity growth and disappointed analysts looking for a slight dip to 51.5.The Eurozone composite PMI, which measures activity in both manufacturing and services, fell from 53.8 to 52.8 in August, missing the 53.4 forecast as readings from both sectors came in below expectations.Closer to home, UK retail sales growth came in at just 0.1% in July, under the 0.4% increase expected by analysts, according to Office for National Statistics. The ONS also released figures showing that while UK public finances improved last month borrowing still remains above the government's target.Looking ahead to the US session, stock futures on Wall Street were edging higher in pre-market trade ahead of a host of economic data, including jobless claims, the Markit manufacturing PMI, existing-home sales and the Philadelphia Fed index.Meanwhile, the Jackson Hole Symposium of central bankers is due to kick off later on with comments from policymakers around the world likely to be closely watched.Mining stocks fallWeak data from top metals consumer China and falling metal prices dampened the demand for mining stocks on Wednesday with Fresnillo, Randgold, Rio Tinto, Anglo American and BHP Billiton trading lower.BHP Billiton was still under pressure in the aftermath of Tuesday's underwhelming plans for a demerger. Chief financial officer Graham Kerr, who is due to be the head of the spin-off company, has been cited as saying that the lack of a share buyback - which many investors had been expecting - was a "sore point", while plans to give shareholders stock in the new firm could have "irritated" some who are not mandated to hold investments in Australia. Kazakh metal miner Kazakhmys hailed progress with a shake-up designed to focus it on the lucrative copper market, but shares fell sharply after it said 2014 gold production was likely to fall short of hopes.Oil and gas stocks were also out of favour including Ophir Energy, Tullow and Shell.Premier Oil was more or less flat after saying it had a "strong six months" with better-than-expected production leading to higher revenues and cash flows. However, it saw a sharp reduction in pre-tax profit in the first half due to impairments.Leading the upside in London were a raft of pharmaceutical and biotechnology stocks, including Astrazeneca, Glaxosmithkline, Shire and Hikma Pharmaceuticals.Financials such as Schroders, Aviva, Old Mutual and Hargreaves Lansdown were also providing a lift.FTSE 100 - RisersSchroders (SDR) 2,385.00p +2.36%AstraZeneca (AZN) 4,372.50p +2.04%GlaxoSmithKline (GSK) 1,438.00p +1.45%CRH (CRH) 1,391.00p +1.31%Ashtead Group (AHT) 945.50p +1.23%Old Mutual (OML) 196.20p +1.13%Barratt Developments (BDEV) 363.50p +1.08%Aviva (AV.) 521.00p +1.07%Diageo (DGE) 1,769.00p +1.00%Hargreaves Lansdown (HL.) 1,120.00p +0.99%FTSE 100 - FallersFresnillo (FRES) 938.50p -3.50%Kingfisher (KGF) 306.60p -1.73%Anglo American (AAL) 1,576.50p -1.10%Randgold Resources Ltd. (RRS) 4,947.00p -1.00%Royal Mail (RMG) 441.80p -0.88%Antofagasta (ANTO) 812.00p -0.85%Rio Tinto (RIO) 3,430.00p -0.81%Standard Chartered (STAN) 1,211.50p -0.78%Pearson (PSON) 1,120.00p -0.71%easyJet (EZJ) 1,330.00p -0.67%FTSE 250 - RisersRank Group (RNK) 166.00p +3.49%Imagination Technologies Group (IMG) 204.90p +3.48%Hikma Pharmaceuticals (HIK) 1,740.00p +2.84%Domino Printing Sciences (DNO) 647.00p +2.70%International Personal Finance (IPF) 519.00p +2.57%Amlin (AML) 439.00p +2.26%Fisher (James) & Sons (FSJ) 1,366.00p +2.25%Euromoney Institutional Investor (ERM) 1,073.00p +2.19%Senior (SNR) 287.70p +2.17%Xaar (XAR) 558.50p +2.10%FTSE 250 - FallersKazakhmys (KAZ) 292.90p -5.06%Thomas Cook Group (TCG) 119.80p -3.39%Just Retirement Group (JRG) 145.30p -3.20%Hochschild Mining (HOC) 162.20p -2.29%Centamin (DI) (CEY) 62.85p -2.26%Petra Diamonds Ltd.(DI) (PDL) 186.80p -2.05%Ophir Energy (OPHR) 225.20p -1.96%African Barrick Gold (ABG) 240.30p -1.52%Serco Group (SRP) 305.10p -1.39%Stock Spirits Group (STCK) 290.50p -1.36%BC
More News
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 08:39

GSK raises $1.5 bln from sale of remaining Haleon stake

May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:33

FTSE 100 ends lower on disappointing corporate updates, BT Group soars

BT Group up after CEO aims for more than double free cash flow

*

Read more
16 May 2024 17:13

TOP NEWS: GSK to sell remaining holding in spin-off Haleon

(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun out almost two years ago.

Read more
16 May 2024 17:02

GSK to sell entire 4.2% remaining stake in Haleon

(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.